Cargando…

The many faces of HFPEF: insights from the CMR substudy of DIAMOND-HFPEF

Detalles Bibliográficos
Autores principales:	Kanagala, Prathap, Cheng, Adrian S, Singh, Anvesha, Khan, Jamal N, Nazir, Sheraz A, Squire, Iain B, Ng, Leong L, McCann, Gerry P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328404/ http://dx.doi.org/10.1186/1532-429X-17-S1-P356

Ejemplares similares

Inter-study reproducibility of circumferential strain and strain rates at 1.5T and 3T: a comparison of tagging and feature tracking
por: Singh, Anvesha, et al.
Publicado: (2014)

Inter-study repeatability of circumferential strain and diastolic strain rate by CMR tagging, feature tracking and tissue tracking in ST-segment elevation myocardial infarction
por: Nazir, Sheraz A., et al.
Publicado: (2020)

Novel plasma and imaging biomarkers in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2015)

Plasma P‐selectin is a predictor of mortality in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2021)

Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trial
por: Backhaus, Sören J., et al.
Publicado: (2022)

Comparison of cardiovascular magnetic resonance feature tracking and tagging for the assessment of left ventricular systolic strain in acute myocardial infarction
por: Khan, Jamal N, et al.
Publicado: (2015)

Comparison of T1-mapping and T2-weighted imaging for diagnostic oedema assessment in ST-segment elevation myocardial infarction
por: Nazir, Sheraz A, et al.
Publicado: (2016)

Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2020)

Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2020)

Effect of late sodium current inhibition on MRI measured diastolic dysfunction and myocardial perfusion reserve in aortic stenosis: a pilot study
por: Singh, Anvesha, et al.
Publicado: (2015)

Prevalence and extent of infarct and microvascular obstruction following a range of reperfusion techniques in ST-elevation myocardial infarction
por: Khan, Jamal N, et al.
Publicado: (2013)

Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes
por: Kanagala, Prathap, et al.
Publicado: (2020)

Obesity and HFpEF
por: Clemenza, Francesco, et al.
Publicado: (2022)

Multi-modality assessment and role of left atrial function as an imaging biomarker in cardiovascular disease
por: Alfuhied, Aseel, et al.
Publicado: (2021)

Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths
por: Khan, Jamal N, et al.
Publicado: (2015)

Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction – implications for clinical trials
por: Kanagala, Prathap, et al.
Publicado: (2018)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Focus on HFpEF in heart failure
por: He, Chunhui, et al.
Publicado: (2022)

Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach
por: Kanagala, Prathap, et al.
Publicado: (2020)

Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction
por: Khan, Jamal N, et al.
Publicado: (2014)

PARIS: A good start for exercise in HFPEF
por: Elamragy, Ahmed A.
Publicado: (2014)

New aspects in cardiorenal syndrome and HFpEF
por: Méndez, Ana Belén, et al.
Publicado: (2022)

Impact of different training modalities on high‐density lipoprotein function in HFpEF patients: a substudy of the OptimEx trial
por: Sowa, Pamela W., et al.
Publicado: (2022)

Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
por: Borlaug, Barry A., et al.
Publicado: (2023)

Impaired Myocardial Bioenergetics in HFpEF and the Role of Antioxidants
por: Hiebert, John B., et al.
Publicado: (2016)

Diet-Induced Obesity HFpEF Murine Models
por: Carbone, Salvatore, et al.
Publicado: (2018)

NEAT HFpEF: Organic nitrates fail to deliver
por: Wagdy, Kerolos, et al.
Publicado: (2016)

A preclinical model for phenogroup 3 HFpEF
por: Yousefi, Keyvan, et al.
Publicado: (2019)

Decoding the Pathophysiology of HFpEF With High-Resolution Phenotyping
por: Houstis, Nicholas E.
Publicado: (2020)

Understanding HFpEF With Obesity: Will Pigs Come to the Rescue?
por: Kass, David A.
Publicado: (2021)

Turning Pressure Into Success: Preload Restriction in HFpEF?
por: Atkins, Jessica, et al.
Publicado: (2021)

Similarities and Differences Between HFmrEF and HFpEF
por: Li, Peixin, et al.
Publicado: (2021)

Renin Feedback Is an Independent Predictor of Outcome in HFpEF
por: Binder, Christina, et al.
Publicado: (2021)

Targeting Collagen Pathways as an HFpEF Therapeutic Strategy
por: Bonanni, Alice, et al.
Publicado: (2023)

The role of imaging in the selection of patients for HFpEF therapy
por: Baron, Tomasz, et al.
Publicado: (2023)

Left-Side Pressure Index for All-Cause Mortality in Older Adults with HFpEF: Diagnostic Potential for HFpEF and Possible View for HFrEF
por: Hoshida, Shiro
Publicado: (2023)

Reply: Diet-Induced Obesity HFpEF Murine Models
por: Valero-Muñoz, Maria, et al.
Publicado: (2018)

Cardiometabolic Heart Failure and HFpEF: Still Chasing Unicorns
por: Sharp, Thomas E., et al.
Publicado: (2019)

Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
por: Grossekettler, Leonie, et al.
Publicado: (2020)

Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities
por: Cuijpers, Ilona, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ptd6jpegq12s4af87h5ur7j1sn